Skip to main content
    X

    Xtant Medical Holdings Inc (XTNT)

    Official site

    HEALTHCARE • MEDICAL DEVICES • AMEX

    $0.30
    -0.02 (-5.68%)

    Market Cap: $45.50M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    63%(20/32)
    Avg Surprise
    -27.00%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.02
    Range$-0.03 - $-0.02
    3 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.01-133.0%
    60d ago$-0.01-133.0%
    30d ago$-0.01-133.0%
    7d ago$-0.02-16.5%
    Current$-0.02
    Revenue Consensus
    $25M
    Range$24M - $27M
    3 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.02
    Range$-0.02 - $-0.02
    1 analysts
    Revenue Consensus
    $29M
    Range$28M - $30M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.02---
    Sep 26EST
    		-$-0.02---
    Jun 26
    Reported Aug 11
    		$-0.07$-0.02-250.00%Miss-333.3%
    Mar 26
    Reported May 13
    		$-0.02$-0.02+0.00%Beat-300.0%
    Dec 25
    Reported Mar 31
    		$-0.01$-0.01-182.00%Miss-5.2%
    Sep 25
    Reported Nov 10
    		$0.01$-0.01+200.00%Beat+125.0%
    Jun 25
    Reported Aug 12
    		$0.03$-0.02+250.00%Beat+250.0%
    Mar 25
    Reported May 12
    		$0.01$-0.01+200.00%Beat+150.0%
    Dec 24
    Reported Mar 6
    		$-0.01$-0.02+33.00%Beat+55.3%
    Sep 24
    Reported Nov 12
    		$-0.04$-0.02-100.00%Miss-157.1%
    Jun 24
    Reported Aug 8
    		$-0.02$-0.02+0.00%Beat+0.0%
    Mar 24
    Reported Apr 1
    		$-0.02$-0.02+0.00%Beat+0.0%
    Dec 23
    Reported Feb 13
    		$-0.03$-0.02-50.00%Miss-50.0%
    Sep 23
    Reported Nov 9
    		$0.07$-0.01+800.00%Beat+333.3%
    Jun 23
    Reported Aug 1
    		$-0.02$-0.02+0.00%Beat+0.0%
    Mar 23
    Reported May 4
    		$-0.02$-0.03+33.33%Beat+33.3%
    Dec 22
    Reported Mar 7
    		$-0.02$-0.02+0.00%Beat+33.3%
    Sep 22
    Reported Nov 3
    		$-0.03N/AN/ABeat-50.0%
    Jun 22
    Reported Aug 4
    		$-0.02N/AN/ABeat-100.0%
    Mar 22
    Reported May 5
    		$-0.03N/AN/ABeat-252.9%
    Dec 21
    Reported Mar 8
    		$-0.03$-0.03+0.00%Beat-200.0%
    Sep 21
    Reported Nov 12
    		$-0.02N/AN/ABeat+80.0%
    Jun 21
    Reported Aug 5
    		$-0.01N/AN/ABeat+94.7%
    Mar 21
    Reported May 11
    		$-0.01$0.00N/ABeat+95.5%
    Dec 20
    Reported Feb 24
    		$-0.01N/A+91.67%Beat+91.7%
    Sep 20
    Reported Oct 29
    		$-0.10$-0.11+9.09%Beat+28.6%
    Jun 20
    Reported Aug 3
    		$-0.19$-0.11-72.73%Miss-26.7%
    Mar 20
    Reported May 7
    		$-0.19$0.00N/ABeat+9.5%
    Dec 19
    Reported Mar 5
    		$-0.12$-0.21+42.86%Beat+47.8%
    Sep 19
    Reported Nov 7
    		$-0.14$-0.28+50.00%Beat+41.7%
    Jun 19
    Reported Aug 8
    		$-0.15N/A+71.15%Beat+60.5%
    Mar 19
    Reported Apr 1
    		$-0.21$-0.36+41.67%Beat+61.1%
    Dec 18
    Reported Dec 31
    		$-0.23$-0.32+28.13%Beat+98.8%
    Sep 18
    Reported Nov 14
    		$-0.24$-0.19-26.32%Miss+95.7%
    Jun 18
    Reported Aug 7
    		$-0.38$-0.27-40.74%Miss+93.9%
    Mar 18
    Reported Apr 2
    		$-0.54$-0.38-42.11%Miss+84.5%
    Dec 17
    Reported Mar 30
    		$-18.77$-3.49-437.82%Miss-468.8%
    Sep 17
    Reported Nov 21
    		$-5.64$-0.48-1075.00%Miss-
    Jun 17
    Reported Aug 9
    		$-6.18$-1.20-415.00%Miss-
    Mar 17
    Reported May 9
    		$-3.48$-3.54+1.69%Beat-
    Dec 16
    Reported Mar 9
    		$-3.30$-2.64-25.00%Miss-

    Key Metrics

    Valuation
    P/E Ratio-3.19EV/EBITDAN/A
    Price/FCF-60.54xFCF Yield-1.65%
    Profitability
    Profit Margin-10.20%Operating Margin-18.10%
    ROE-25.20%ROIC-10.78%
    Financial Health
    Debt/Equity0.57xInterest Coverage2.88x
    Current Ratio2.16xQuick Ratio1.05x
    Trading Statistics
    Beta-0.20Avg Volume166.01K
    52-Week High$0.9552-Week Low$0.27

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.32
    SMA 20$0.34
    SMA 50$0.35
    SMA 200$0.48
    EMA 10$0.32
    EMA 20$0.33
    EMA 50$0.36
    EMA 200$0.46

    MACD

    Line: -0.01Signal: -0.01Hist: -0.00

    ADX

    ADX: 14.9+DI: 15.1-DI: 19.7

    Aroon & PSAR

    Aroon Up48.0
    Aroon Down100.0
    PSAR$0.36

    Bollinger Bands

    Upper Band$0.38
    Lower Band$0.30
    %B Position2606%(Upper)
    Band Width0.06

    RSI (14-Day)

    Neutral
    33.4

    Momentum Oscillators

    Stoch %K5.9
    Stoch %D8.7
    Williams %R-99.5
    ROC (10d)-15.2%
    Momentum-0.05
    CCI (20d)-122.9
    MFI (14d)36.3

    Volatility Measures

    ATR (14d)$0.02(7.9%)
    StdDev (20d)0.02
    Hist Vol50.8%(High)

    Volume Flow

    VWAP$0.31
    OBV101.4M
    AD Line-50.2M
    CMF (20d)-0.324

    Volume Metrics

    Avg Vol (20d)159.6K
    Vol Ratio0.8x
    VWMA (20d)$0.34

    Pivot Points

    R3$0.34
    R2$0.33
    R1$0.32
    Pivot Point$0.32
    S1$0.31
    S2$0.31
    S3$0.30

    Advanced Oscillators

    TSI-16.61
    Ultimate Osc29.6
    KST-40.70

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$23.03M$20.88M$32.36M$33.26M$35.41M$32.90M$31.51M$27.94M$29.94M$27.87M$28.11M$25.02M
    Cost of Revenue$9.70M$8.91M$14.60M$11.26M$11.13M$12.66M$15.49M$11.63M$11.36M$10.57M$10.97M$9.69M
    Gross Profit$13.33M$11.97M$17.75M$21.99M$24.28M$20.24M$16.02M$16.31M$18.58M$17.30M$17.14M$15.33M
    Operating Expenses$22.50M$14.89M$18.70M$19.45M$19.66M$19.18M$17.91M$20.08M$21.53M$20.77M$20.94M$18.72M
    R&D$695,000$435,000$459,000$634,000$566,000$443,000$521,000$701,000$636,000$527,000$492,000$490,000
    SG&A$6.44M$6.27M$7.29M$7.07M$7.48M$7.53M$5.70M$7.49M$7.71M$7.79M$8.87M$7.14M
    Operating Income$-9,169,000$-2,923,000$-944,000$2.54M$4.62M$1.06M$-1,881,000$-3,777,000$-2,946,000$-3,470,000$-3,806,000$-3,385,000
    Interest Income$1,000$219,000$0$0$0$0$0$0$0$0$15,000$48,000
    Interest Expense$542,000$599,000$718,000$904,000$1.00M$1.04M$1.13M$1.20M$992,000$835,000$817,000$760,000
    Income Before Tax$-9,340,000$-3,062,000$1.60M$1.56M$3.81M$33,000$-3,143,000$-4,962,000$-3,825,000$-4,332,000$-3,726,000$6.93M
    Income Tax Expense$73,000$27,000$1.54M$257,000$255,000$-25,000$21,000$62,000$36,000$68,000$577,000$-2,300,000
    Net Income$-9,413,000$-3,089,000$57,000$1.31M$3.55M$58,000$-3,164,000$-5,024,000$-3,861,000$-4,400,000$-4,303,000$9.23M
    EBITDA$-8,291,000$-2,148,000$4.04M$3.63M$5.98M$2.15M$-873,000$-2,717,000$-1,835,000$-2,453,000$-1,907,000$8.53M
    EBIT$-8,799,000$-2,682,000$2.22M$2.47M$4.81M$1.08M$-2,021,000$-3,790,000$-2,833,000$-3,458,000$-2,924,000$7.64M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about XTNT

    News

    Xtant Medical reports an 85.30 percent short-interest drop for Xtant Medical stock

    Xtant Medical (XTNT) experienced an 85.30% drop in short interest, falling to 268,742 shares as of September 15...

    ad-hoc-news.de•10/15/26•Somewhat-Bearish

    Xtant Medical reports an 85.30 percent short-interest drop for Xtant Medical stock

    Xtant Medical (XTNT) saw an 85.30% drop in short interest to 268,742 shares as of September 15, 2026. This significant decrease was reported by MarketBeat...

    ad-hoc-news.de•10/15/26•Somewhat-Bullish

    Xtant Medical stock sits 66.32 percent below its 52-week high

    Xtant Medical (XTNT) stock is currently 66.32 percent below its 52-week high of USD 0.95, trading at USD 0.32 as of October 6, 2026. The company reported Q2 2026 revenue of USD 23.03 million, missing analyst estimates...

    AD HOC NEWS•10/7/26•Somewhat-Bearish

    Xtant Medical stock reports a second quarter revenue miss

    Xtant Medical (XTNT) reported a second-quarter revenue of USD 23.03 million, missing the analyst estimate of USD 24.88 million...

    AD HOC NEWS•9/29/26•Bearish

    Xtant Medical stock draws a USD 1.00 target from Lucid Capital

    Lucid Capital Markets initiated coverage on Xtant Medical stock with a Buy rating and a $1.00 price target, despite the company reporting a significant 35% year-over-year revenue decline and a net loss in its second...

    AD HOC NEWS•9/25/26•Neutral

    XTNT Valuation and Fair Value

    P/E
    -3.2x
    Forward P/E
    34.8x
    P/FCF
    -60.5x
    PEG
    1.7x
    P/B
    1.1x
    See GNG's fair value

    XTNT Profitability: Margins, ROIC and FCF

    Gross margin
    59.4%
    Operating margin
    -18.1%
    Net margin
    -10.2%
    ROIC
    -10.8%
    ROE
    -25.2%
    FCF margin
    -0.6%
    FCF yield
    -1.7%

    XTNT Competitors

    CompanyTicker
    Celularity IncCELU
    INmune Bio IncINMB
    LAVA Therapeutics NVLVTX
    Serina Therapeutics IncSER
    Hyperion DeFi, Inc.HYPD
    Rapid Micro Biosystems IncRPID
    ImageneBio, Inc.IMA
    Dogwood Therapeutics, Inc.DWTX

    Sector: Healthcare

    XTNT Bull Case vs Bear Case

    Bear case

    • XTNT has a -10.2% net profit margin.
    • XTNT's quarterly revenue changed -35.0% year over year.

    XTNT Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    18.9%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.02
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 1 down

    Frequently Asked Questions About XTNT

    Does XTNT pay dividends?

    Xtant Medical Holdings Inc (XTNT) does not currently pay a regular dividend.

    What is XTNT's market cap?

    Xtant Medical Holdings Inc (XTNT) has a market capitalization of $45.50M with a current stock price of $0.30.

    Related stocks

    Sector: Healthcare

    All stocks starting with X

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In